 REDWOOD CITY, Calif., Aug. 27, 2021 GLOBE NEWSWIRE -- Coherus BioSciences, Inc. Coherus or the Company, Nasdaq: CHRS, today announced that effective Aug. 26, 2021, the compensation committee of the Companys board of directors granted options to purchase an aggregate of 278,000 shares of the common stock of the Company to newly hired employees with a per share exercise price of 15.82, the closing trading price on the grant date. Two newly hired Vice Presidents were each granted options for 45,000 shares; fifteen additional non-officer employees were granted options to purchase an aggregate of 188,000 shares. 